3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
6
Breast Neoplasms
5
Myeloproliferative Disorders
3
Melanoma
3
Lung Neoplasms
3
Triple Negative Breast Neoplasms
2
Skin Neoplasms
2
Leukemia, Myeloid, Acute
2
Head and Neck Neoplasms
2
von Hippel-Lindau Disease
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Pyruvate Kinase Deficiency of Red Cells
1
Precancerous Conditions
1
Pancreatic Cyst
1
Neuroendocrine Tumors
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Marijuana Abuse
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Interventions
pertuzumab
3
Trastuzumab
3
Docetaxel
2
tucatinib
1
atezolizumab
1
Paclitaxel
1
Neoadjuvant Therapy
1
Genetic Testing
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
Blood Specimen Collection
×
30 days
×
Clear all
NCT04638725
2026-06-04
SIGHER
Centre Paul Strauss
Recruiting
9,000 enrolled